-
1
-
-
84875006287
-
-
The National Institute of Health Accessed March 15, 2009
-
The National Institute of Health. Office of rare diseases. Available at: http://nih.gov/. Accessed March 15, 2009.
-
Office of Rare Diseases
-
-
-
2
-
-
53749090994
-
Targeted therapies in gastrointestinal stromal tumors
-
Antonescu CR. Targeted therapies in gastrointestinal stromal tumors. Semin Diagn Pathol. 2008;25:295-303.
-
(2008)
Semin Diagn Pathol
, vol.25
, pp. 295-303
-
-
Antonescu, C.R.1
-
3
-
-
0030004962
-
Prognostic factors in angiosarcoma: A multivariate analysis of 55 cases
-
Naka N, Ohsawa M, Tomita Y, et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol. 1996;61:170-176.
-
(1996)
J Surg Oncol
, vol.61
, pp. 170-176
-
-
Naka, N.1
Ohsawa, M.2
Tomita, Y.3
-
4
-
-
33749545556
-
A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy
-
Fury MG, Antonescu CR, Van Zee KJ, et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 2005;11:241-247.
-
(2005)
Cancer J
, vol.11
, pp. 241-247
-
-
Fury, M.G.1
Antonescu, C.R.2
Van Zee, K.J.3
-
5
-
-
37349120536
-
Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: A retrospective study of 161 cases
-
Fayette J, Martin E, Piperno-Neumann S, et al. Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol. 2007;18:2030-2036.
-
(2007)
Ann Oncol
, vol.18
, pp. 2030-2036
-
-
Fayette, J.1
Martin, E.2
Piperno-Neumann, S.3
-
6
-
-
0022589265
-
The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma
-
Otis CN, Peschel R, McKhann C, et al. The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma. Cancer. 1986;57: 2130-2134.
-
(1986)
Cancer
, vol.57
, pp. 2130-2134
-
-
Otis, C.N.1
Peschel, R.2
McKhann, C.3
-
7
-
-
0023192537
-
Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema
-
Benda JA, Al-Jurf AS, Benson AB III. Angiosarcoma of the breast following segmental mastectomy complicated by lymphedema. Am J Clin Pathol. 1987;87:651-655.
-
(1987)
Am J Clin Pathol
, vol.87
, pp. 651-655
-
-
Benda, J.A.1
Al-Jurf, A.S.2
Benson, A.B.3
-
8
-
-
0034534391
-
Confirmed angiosarcoma: Prognostic factors and outcome in 50 prospectively followed patients
-
Espat NJ, Lewis JJ, Woodruff JM, et al. Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients. Sarcoma. 2000; 4:173-177.
-
(2000)
Sarcoma
, vol.4
, pp. 173-177
-
-
Espat, N.J.1
Lewis, J.J.2
Woodruff, J.M.3
-
9
-
-
33750604292
-
Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors
-
Rubin BP, Fletcher CD, Inwards C, et al. Protocol for the examination of specimens from patients with soft tissue tumors of intermediate malignant potential, malignant soft tissue tumors, and benign/locally aggressive and malignant bone tumors. Arch Pathol Lab Med. 2006;130:1616-1629.
-
(2006)
Arch Pathol Lab Med
, vol.130
, pp. 1616-1629
-
-
Rubin, B.P.1
Fletcher, C.D.2
Inwards, C.3
-
10
-
-
0142189433
-
-
Flecther CD, Unni KK, Mertens F, eds. World health Organization. Classification of Tumors Lyon, France: IARC Press
-
Flecther CD, Unni KK, Mertens F, eds. World health Organization. Classification of Tumors. Pathology and Genetics of Tumors of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
-
(2002)
Pathology and Genetics of Tumors of Soft Tissue and Bone
-
-
-
11
-
-
37549041353
-
Sporadic cutaneous angio-sarcomas: A proposal for risk stratification based on 69 cases
-
Deyrup AT, McKenney JK, Tighiouart M, et al. Sporadic cutaneous angio-sarcomas: a proposal for risk stratification based on 69 cases. Am J Surg Pathol. 2008;32:72-77.
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 72-77
-
-
Deyrup, A.T.1
McKenney, J.K.2
Tighiouart, M.3
-
12
-
-
52649117042
-
Midkine enhances soft-tissue sarcoma growth: A possible novel therapeutic target
-
Jin Z, Lahat G, Korchin B, et al. Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic target. Clin Cancer Res. 2008;14:5033-5042.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5033-5042
-
-
Jin, Z.1
Lahat, G.2
Korchin, B.3
-
13
-
-
65249117712
-
Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas
-
Lahat G, Lazar A, Wang X, et al. Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res. 2009;15:2637-2646.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2637-2646
-
-
Lahat, G.1
Lazar, A.2
Wang, X.3
-
14
-
-
66849131261
-
Dual targeting of AKT and mammalian target of rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor.
-
press
-
Zou CY, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther. In press.
-
Mol Cancer Ther
-
-
Zou, C.Y.1
Smith, K.D.2
Zhu, Q.S.3
-
15
-
-
51649102507
-
New perspectives for staging and prognosis in soft tissue sarcoma
-
Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739-2748.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2739-2748
-
-
Lahat, G.1
Tuvin, D.2
Wei, C.3
-
16
-
-
29144524677
-
Angiosarcoma of the breast
-
Vorburger SA, Xing Y, Hunt KK, et al. Angiosarcoma of the breast. Cancer. 2005;104:2682-2688.
-
(2005)
Cancer
, vol.104
, pp. 2682-2688
-
-
Vorburger, S.A.1
Xing, Y.2
Hunt, K.K.3
-
17
-
-
34249865898
-
Treatment and outcome of 82 patients with angiosarcoma
-
Abraham JA, Hornicek FJ, Kaufman AM, et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol. 2007;14:1953-1967.
-
(2007)
Ann Surg Oncol
, vol.14
, pp. 1953-1967
-
-
Abraham, J.A.1
Hornicek, F.J.2
Kaufman, A.M.3
-
18
-
-
42949119654
-
Prognostic factors for adult sarcomas of head and neck
-
Penel N, Mallet Y, Robin YM, et al. Prognostic factors for adult sarcomas of head and neck. Int J Oral Maxillofac Surg. 2008;37:428-432.
-
(2008)
Int J Oral Maxillofac Surg
, vol.37
, pp. 428-432
-
-
Penel, N.1
Mallet, Y.2
Robin, Y.M.3
-
19
-
-
55949086834
-
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX study
-
Penel N, Bui BN, Bay JO, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol. 2008;26: 5269-5274.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5269-5274
-
-
Penel, N.1
Bui, B.N.2
Bay, J.O.3
-
20
-
-
0030700784
-
A phase i study of ambulatory continuous infusion paclitaxel
-
Skubitz KM. A phase I study of ambulatory continuous infusion paclitaxel. Anticancer Drugs. 1997;8:823-828.
-
(1997)
Anticancer Drugs
, vol.8
, pp. 823-828
-
-
Skubitz, K.M.1
-
21
-
-
0033571557
-
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
-
Fata F, O'Reilly E, Ilson D, et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer. 1999;86:2034-2037.
-
(1999)
Cancer
, vol.86
, pp. 2034-2037
-
-
Fata, F.1
O'Reilly, E.2
Ilson, D.3
-
22
-
-
0031709550
-
Phase II trial of paclitaxel in patients with soft-tissue sarcoma
-
Casper ES, Waltzman RJ, Schwartz GK, et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest. 1998;16:442-446.
-
(1998)
Cancer Invest
, vol.16
, pp. 442-446
-
-
Casper, E.S.1
Waltzman, R.J.2
Schwartz, G.K.3
-
23
-
-
38849182248
-
Improved outcome with multimodality therapy in primary cardiac angiosarcoma
-
Pigott C, Welker M, Khosla P, et al. Improved outcome with multimodality therapy in primary cardiac angiosarcoma. Nat Clin Pract Oncol. 2008;5:112-115.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 112-115
-
-
Pigott, C.1
Welker, M.2
Khosla, P.3
-
25
-
-
2542484761
-
Cutaneous angiosarcoma following breast-conserving surgery and radiation: An analysis of 27 cases
-
Billings SD, McKenney JK, Folpe AL, et al. Cutaneous angiosarcoma following breast-conserving surgery and radiation: an analysis of 27 cases. Am J Surg Pathol. 2004;28:781-788.
-
(2004)
Am J Surg Pathol
, vol.28
, pp. 781-788
-
-
Billings, S.D.1
McKenney, J.K.2
Folpe, A.L.3
-
26
-
-
33645057934
-
Grading of soft tissue sarcomas: The challenge of providing precise information in an imprecise world
-
Deyrup AT, Weiss SW. Grading of soft tissue sarcomas: the challenge of providing precise information in an imprecise world. Histopathology. 2006; 48:42-50.
-
(2006)
Histopathology
, vol.48
, pp. 42-50
-
-
Deyrup, A.T.1
Weiss, S.W.2
-
27
-
-
58749109288
-
Primary angiosarcoma of the breast: Clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic
-
Nascimento AF, Raut CP, Fletcher CD. Primary angiosarcoma of the breast: clinicopathologic analysis of 49 cases, suggesting that grade is not prognostic. Am J Surg Pathol. 2008;32:1896-1904.
-
(2008)
Am J Surg Pathol
, vol.32
, pp. 1896-1904
-
-
Nascimento, A.F.1
Raut, C.P.2
Fletcher, C.D.3
-
28
-
-
0029686511
-
Vascular tumors: An update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms
-
Fletcher CD. Vascular tumors: an update with emphasis on the diagnosis of angiosarcoma and borderline vascular neoplasms. Monogr Pathol. 1996;38: 181-206.
-
(1996)
Monogr Pathol
, vol.38
, pp. 181-206
-
-
Fletcher, C.D.1
-
29
-
-
57149117848
-
A decade of tissue microarrays: Progress in the discovery and validation of cancer biomarkers
-
Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol. 2008;26: 5630-5637.
-
(2008)
J Clin Oncol
, vol.26
, pp. 5630-5637
-
-
Camp, R.L.1
Neumeister, V.2
Rimm, D.L.3
-
30
-
-
33845949059
-
Secondary breast angiosarcoma: Lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report
-
Tomasello L, Gardin G, Boccardo F. Secondary breast angiosarcoma: lethal response to anti-angiogenic therapy with paclitaxel chemotherapy. A case report. Anticancer Res. 2006;26:4775-4777.
-
(2006)
Anticancer Res
, vol.26
, pp. 4775-4777
-
-
Tomasello, L.1
Gardin, G.2
Boccardo, F.3
-
31
-
-
0029564159
-
Expression of vascular endothe-lial growth factor and its receptor mRNA in angiosarcoma
-
Hashimoto M, Ohsawa M, Ohnishi A, et al. Expression of vascular endothe-lial growth factor and its receptor mRNA in angiosarcoma. Lab Invest. 1995;73:859-863.
-
(1995)
Lab Invest
, vol.73
, pp. 859-863
-
-
Hashimoto, M.1
Ohsawa, M.2
Ohnishi, A.3
-
32
-
-
39149092712
-
Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies
-
Koontz BF, Miles EF, Rubio MA, et al. Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: two case studies. Head Neck. 2008;30:262-266.
-
(2008)
Head Neck
, vol.30
, pp. 262-266
-
-
Koontz, B.F.1
Miles, E.F.2
Rubio, M.A.3
-
33
-
-
43249092388
-
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors
-
Kuwai T, Nakamura T, Sasaki T, et al. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia. 2008;10:489-500.
-
(2008)
Neoplasia
, vol.10
, pp. 489-500
-
-
Kuwai, T.1
Nakamura, T.2
Sasaki, T.3
-
34
-
-
0034083341
-
KIT expression in angiosarcomas and fetal endothelial cells: Lack of mutations of exon 11 and exon 17 of C-kit
-
Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol. 2000;13:536-541.
-
(2000)
Mod Pathol
, vol.13
, pp. 536-541
-
-
Miettinen, M.1
Sarlomo-Rikala, M.2
Lasota, J.3
-
35
-
-
0028116487
-
Expression of c-kit and kit ligand proteins in normal human tissues
-
Lammie A, Drobnjak M, Gerald W, et al. Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994;42:1417-1425.
-
(1994)
J Histochem Cytochem
, vol.42
, pp. 1417-1425
-
-
Lammie, A.1
Drobnjak, M.2
Gerald, W.3
-
36
-
-
62549158253
-
Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDG-FRA mutations
-
Kiesel H, Muller AM, Schmitt-Graeff A, et al. Dramatic and durable efficacy of imatinib in an advanced angiosarcoma without detectable KIT and PDG-FRA mutations. Cancer Biol Ther. 2009;8:319-321.
-
(2009)
Cancer Biol Ther
, vol.8
, pp. 319-321
-
-
Kiesel, H.1
Muller, A.M.2
Schmitt-Graeff, A.3
-
37
-
-
0000440912
-
Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase
-
Chang HW, Aoki M, Fruman D, et al. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 1997;276:1848-1850.
-
(1997)
Science
, vol.276
, pp. 1848-1850
-
-
Chang, H.W.1
Aoki, M.2
Fruman, D.3
-
38
-
-
0032443803
-
The akt kinase: Molecular determinants of oncogenicity
-
Aoki M, Batista O, Bellacosa A, et al. The akt kinase: molecular determinants of oncogenicity. Proc Natl Acad Sci USA. 1998;95:14950-14955.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 14950-14955
-
-
Aoki, M.1
Batista, O.2
Bellacosa, A.3
-
39
-
-
34247373748
-
AKT1 overexpression in endo-thelial cells leads to the development of cutaneous vascular malformations in vivo
-
Perry B, Banyard J, McLaughlin ER, et al. AKT1 overexpression in endo-thelial cells leads to the development of cutaneous vascular malformations in vivo. Arch Dermatol. 2007;143:504-506.
-
(2007)
Arch Dermatol
, vol.143
, pp. 504-506
-
-
Perry, B.1
Banyard, J.2
McLaughlin, E.R.3
-
40
-
-
33746800144
-
Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin
-
Phung TL, Ziv K, Dabydeen D, et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell. 2006;10: 159-170.
-
(2006)
Cancer Cell
, vol.10
, pp. 159-170
-
-
Phung, T.L.1
Ziv, K.2
Dabydeen, D.3
-
41
-
-
24644509362
-
Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma
-
Dickerson EB, Thomas R, Fosmire SP, et al. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma. Vet Pathol. 2005;42:618-632.
-
(2005)
Vet Pathol
, vol.42
, pp. 618-632
-
-
Dickerson, E.B.1
Thomas, R.2
Fosmire, S.P.3
-
42
-
-
33846295218
-
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
-
Paik JH, Kollipara R, Chu G, et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 2007;128: 309-323.
-
(2007)
Cell
, vol.128
, pp. 309-323
-
-
Paik, J.H.1
Kollipara, R.2
Chu, G.3
-
43
-
-
66849131261
-
Dual targeting of AKT and mammalian target of Rapamycin: A potential therapeutic approach for malignant peripheral nerve sheath tumor
-
press
-
Zou C, Smith KD, Zhu QS, et al. Dual targeting of AKT and mammalian target of Rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor. Mol Cancer Ther. In press.
-
Mol Cancer Ther
-
-
Zou, C.1
Smith, K.D.2
Zhu, Q.S.3
-
44
-
-
0037020044
-
Identification of TOR signaling complexes: More TORC for the cell growth engine
-
Abraham RT. Identification of TOR signaling complexes: more TORC for the cell growth engine. Cell. 2002;4:9-12.
-
(2002)
Cell
, vol.4
, pp. 9-12
-
-
Abraham, R.T.1
-
45
-
-
23144467910
-
An expanding role for mTOR in cancer
-
Guertin DA, Sabatini DM. An expanding role for mTOR in cancer. Trends Mol Med. 2005;11:353-361.
-
(2005)
Trends Mol Med
, vol.11
, pp. 353-361
-
-
Guertin, D.A.1
Sabatini, D.M.2
|